KALA - Kala Pharmaceuticals EPS misses by $0.04 misses on revenue November, 07 2019 07:03 AM Kala Pharmaceuticals Inc. Kala Pharmaceuticals (NASDAQ:KALA): Q3 GAAP EPS of -$0.68 misses by $0.04.More news on: Kala Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...